NPI: 1073575171 · FAIRFAX, SC 29827 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,263 | $132K |
| 2019 | 11,430 | $121K |
| 2020 | 9,953 | $152K |
| 2021 | 5,293 | $92K |
| 2022 | 3,649 | $2K |
| 2023 | 1,072 | $136.34 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 17,987 | 1,815 | $239K |
| A4657 | Syringe, with or without needle, each | 2,343 | 1,087 | $207K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 3,460 | 805 | $45K |
| J1756 | Injection, iron sucrose, 1 mg | 1,423 | 467 | $3K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 249 | 143 | $3K |
| 83970 | 862 | 772 | $958.07 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,889 | 736 | $458.76 |
| 82728 | 836 | 769 | $353.26 | |
| 83550 | 855 | 771 | $324.80 | |
| 83540 | 850 | 769 | $302.85 | |
| 85045 | 820 | 758 | $190.37 | |
| 85041 | 853 | 782 | $145.36 | |
| 82108 | 231 | 212 | $141.06 | |
| 85048 | 850 | 780 | $131.40 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 79 | 64 | $106.02 |
| 90662 | 12 | 12 | $10.74 | |
| G0008 | Administration of influenza virus vaccine | 61 | 58 | $0.00 |